View in EDS HTML Full Text PDF Full Text

Drug-use disorders in the Eastern Mediterranean Region: a glance at GBD 2019 findings.

Saved in:
Bibliographic Details
Title: Drug-use disorders in the Eastern Mediterranean Region: a glance at GBD 2019 findings.
Authors: Amirkafi, Ali (AUTHOR), Mohammadi, Faezeh (AUTHOR), Tehrani-Banihashemi, Arash (AUTHOR), GBD Collaborators (AUTHOR), Abbasi-Kangevari, Mohsen (AUTHOR), Abbasi-Kangevari, Zeinab (AUTHOR), Abdollahi, Mohammad (AUTHOR), Abu-Gharbieh, Eman (AUTHOR), Aghaei, Abbas (AUTHOR), Ahmadi, Ali (AUTHOR), Ajami, Marjan (AUTHOR), Al Thaher, Yazan (AUTHOR), Alhalaiqa, Fadwa (AUTHOR), Alimohamadi, Yousef (AUTHOR), Al-Maweri, Sadeq Ali (AUTHOR), Almustanyir, Sami (AUTHOR), Amir-Behghadami, Mehrdad (AUTHOR), Amiri, Sohrab (AUTHOR), Arabloo, Jalal (AUTHOR), Ashraf, Tahira (AUTHOR)
Source: Social Psychiatry & Psychiatric Epidemiology. Jul2024, Vol. 59 Issue 7, p1113-1127. 15p.
Subjects: Substance-induced disorders, Global burden of disease, Naltrexone, Drug overdose
Geographic Terms: Iran, Libya, United Arab Emirates
Abstract: Purpose: The aim of this study is to investigate drug use disorders which are a major cause of Disability Adjusted Life Years (DALYs) in the Eastern Mediterranean Region (EMR). Methods: This article is a part of the global burden of diseases (GBD), injuries, and risk factors 2019 study. The GBD modeling approach was used to estimate population-level prevalence of drug use disorders. We combined these estimates with disability weights to calculate years of life lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 1990–2019. Results: It is estimated that in 2019 in EMR around 3.4 million people have drug use disorder which has increased by 137% compared to 1990. Also, in 2019, DALY number for drug use disorders was 1217.9 (95% UI: 940.4, 1528.9) thousand years and 7645 (95% UI: 6793.7, 8567.9) deaths occurred. The DALY rate increased 39.6% in the region since1990, whereas the global rate increased by 24.4%. United Arab Emirates, Libya, and Iran were most affected by drug use disorders with the highest rates of age-standardized DALY in EMR in 2019. The most prevalent drug use disorder in the region is opioid use which is accountable for 80% of all drug use disorders DALYs. Conclusion: Despite many interventions, drug use disorders are still responsible for high rates of DALY in the region which has increased since 1990 in both males and females; more comprehensive policies, better control measures and proper education could reduce the adverse effects. [ABSTRACT FROM AUTHOR]
Copyright of Social Psychiatry & Psychiatric Epidemiology is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 177897078
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Drug-use disorders in the Eastern Mediterranean Region: a glance at GBD 2019 findings.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Amirkafi%2C+Ali%22">Amirkafi, Ali</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mohammadi%2C+Faezeh%22">Mohammadi, Faezeh</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tehrani-Banihashemi%2C+Arash%22">Tehrani-Banihashemi, Arash</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22GBD+Collaborators%22">GBD Collaborators</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Abbasi-Kangevari%2C+Mohsen%22">Abbasi-Kangevari, Mohsen</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Abbasi-Kangevari%2C+Zeinab%22">Abbasi-Kangevari, Zeinab</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Abdollahi%2C+Mohammad%22">Abdollahi, Mohammad</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Abu-Gharbieh%2C+Eman%22">Abu-Gharbieh, Eman</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aghaei%2C+Abbas%22">Aghaei, Abbas</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ahmadi%2C+Ali%22">Ahmadi, Ali</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ajami%2C+Marjan%22">Ajami, Marjan</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Al+Thaher%2C+Yazan%22">Al Thaher, Yazan</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alhalaiqa%2C+Fadwa%22">Alhalaiqa, Fadwa</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alimohamadi%2C+Yousef%22">Alimohamadi, Yousef</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Al-Maweri%2C+Sadeq+Ali%22">Al-Maweri, Sadeq Ali</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Almustanyir%2C+Sami%22">Almustanyir, Sami</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Amir-Behghadami%2C+Mehrdad%22">Amir-Behghadami, Mehrdad</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Amiri%2C+Sohrab%22">Amiri, Sohrab</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Arabloo%2C+Jalal%22">Arabloo, Jalal</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ashraf%2C+Tahira%22">Ashraf, Tahira</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Social+Psychiatry+%26+Psychiatric+Epidemiology%22">Social Psychiatry & Psychiatric Epidemiology</searchLink>. Jul2024, Vol. 59 Issue 7, p1113-1127. 15p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Substance-induced+disorders%22">Substance-induced disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Global+burden+of+disease%22">Global burden of disease</searchLink><br /><searchLink fieldCode="DE" term="%22Naltrexone%22">Naltrexone</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+overdose%22">Drug overdose</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Iran%22">Iran</searchLink><br /><searchLink fieldCode="DE" term="%22Libya%22">Libya</searchLink><br /><searchLink fieldCode="DE" term="%22United+Arab+Emirates%22">United Arab Emirates</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Purpose: The aim of this study is to investigate drug use disorders which are a major cause of Disability Adjusted Life Years (DALYs) in the Eastern Mediterranean Region (EMR). Methods: This article is a part of the global burden of diseases (GBD), injuries, and risk factors 2019 study. The GBD modeling approach was used to estimate population-level prevalence of drug use disorders. We combined these estimates with disability weights to calculate years of life lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 1990–2019. Results: It is estimated that in 2019 in EMR around 3.4 million people have drug use disorder which has increased by 137% compared to 1990. Also, in 2019, DALY number for drug use disorders was 1217.9 (95% UI: 940.4, 1528.9) thousand years and 7645 (95% UI: 6793.7, 8567.9) deaths occurred. The DALY rate increased 39.6% in the region since1990, whereas the global rate increased by 24.4%. United Arab Emirates, Libya, and Iran were most affected by drug use disorders with the highest rates of age-standardized DALY in EMR in 2019. The most prevalent drug use disorder in the region is opioid use which is accountable for 80% of all drug use disorders DALYs. Conclusion: Despite many interventions, drug use disorders are still responsible for high rates of DALY in the region which has increased since 1990 in both males and females; more comprehensive policies, better control measures and proper education could reduce the adverse effects. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Social Psychiatry & Psychiatric Epidemiology is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=177897078
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00127-023-02587-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 15
        StartPage: 1113
    Subjects:
      – SubjectFull: Substance-induced disorders
        Type: general
      – SubjectFull: Global burden of disease
        Type: general
      – SubjectFull: Naltrexone
        Type: general
      – SubjectFull: Drug overdose
        Type: general
      – SubjectFull: Iran
        Type: general
      – SubjectFull: Libya
        Type: general
      – SubjectFull: United Arab Emirates
        Type: general
    Titles:
      – TitleFull: Drug-use disorders in the Eastern Mediterranean Region: a glance at GBD 2019 findings.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Amirkafi, Ali
      – PersonEntity:
          Name:
            NameFull: Mohammadi, Faezeh
      – PersonEntity:
          Name:
            NameFull: Tehrani-Banihashemi, Arash
      – PersonEntity:
          Name:
            NameFull: GBD Collaborators
      – PersonEntity:
          Name:
            NameFull: Abbasi-Kangevari, Mohsen
      – PersonEntity:
          Name:
            NameFull: Abbasi-Kangevari, Zeinab
      – PersonEntity:
          Name:
            NameFull: Abdollahi, Mohammad
      – PersonEntity:
          Name:
            NameFull: Abu-Gharbieh, Eman
      – PersonEntity:
          Name:
            NameFull: Aghaei, Abbas
      – PersonEntity:
          Name:
            NameFull: Ahmadi, Ali
      – PersonEntity:
          Name:
            NameFull: Ajami, Marjan
      – PersonEntity:
          Name:
            NameFull: Al Thaher, Yazan
      – PersonEntity:
          Name:
            NameFull: Alhalaiqa, Fadwa
      – PersonEntity:
          Name:
            NameFull: Alimohamadi, Yousef
      – PersonEntity:
          Name:
            NameFull: Al-Maweri, Sadeq Ali
      – PersonEntity:
          Name:
            NameFull: Almustanyir, Sami
      – PersonEntity:
          Name:
            NameFull: Amir-Behghadami, Mehrdad
      – PersonEntity:
          Name:
            NameFull: Amiri, Sohrab
      – PersonEntity:
          Name:
            NameFull: Arabloo, Jalal
      – PersonEntity:
          Name:
            NameFull: Ashraf, Tahira
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: Jul2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 09337954
          Numbering:
            – Type: volume
              Value: 59
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Social Psychiatry & Psychiatric Epidemiology
              Type: main
ResultId 1